133 related articles for article (PubMed ID: 29096939)
21. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
[TBL] [Abstract][Full Text] [Related]
22. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].
Vasen HF
Fam Cancer; 2005; 4(3):219-25. PubMed ID: 16136381
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
24. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
25. [Hereditary nonpolyposis colorectal carcinoma: state of the art].
Holinski-Feder E; Morak M
Dtsch Med Wochenschr; 2008 Aug; 133(33):1690-5. PubMed ID: 18686212
[TBL] [Abstract][Full Text] [Related]
26. SETD6 dominant negative mutation in familial colorectal cancer type X.
Martín-Morales L; Feldman M; Vershinin Z; Garre P; Caldés T; Levy D
Hum Mol Genet; 2017 Nov; 26(22):4481-4493. PubMed ID: 28973356
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
28. Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
Choi YH; Lakhal-Chaieb L; Kröl A; Yu B; Buchanan D; Ahnen D; Le Marchand L; Newcomb PA; Win AK; Jenkins M; Lindor NM; Briollais L
J Natl Cancer Inst; 2019 Jul; 111(7):675-683. PubMed ID: 30380125
[TBL] [Abstract][Full Text] [Related]
29. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
Therkildsen C; Rasmussen M; Smith-Hansen L; Kallemose T; Lindberg LJ; Nilbert M
BMC Cancer; 2020 Apr; 20(1):345. PubMed ID: 32321466
[TBL] [Abstract][Full Text] [Related]
30. Update on Hereditary Colorectal Cancer.
DA Silva FC; Wernhoff P; Dominguez-Barrera C; Dominguez-Valentin M
Anticancer Res; 2016 Sep; 36(9):4399-405. PubMed ID: 27630275
[TBL] [Abstract][Full Text] [Related]
31. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
32. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
33. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
34. New insights on familial colorectal cancer type X syndrome.
Garcia FAO; de Andrade ES; de Campos Reis Galvão H; da Silva Sábato C; Campacci N; de Paula AE; Evangelista AF; Santana IVV; Melendez ME; Reis RM; Palmero EI
Sci Rep; 2022 Feb; 12(1):2846. PubMed ID: 35181726
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
[TBL] [Abstract][Full Text] [Related]
36. GALNT12 is not a major contributor of familial colorectal cancer type X.
Seguí N; Pineda M; Navarro M; Lázaro C; Brunet J; Infante M; Durán M; Soto JL; Blanco I; Capellá G; Valle L
Hum Mutat; 2014 Jan; 35(1):50-2. PubMed ID: 24115450
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients.
Spaepen M; Vankeirsbilck B; Van Opstal S; Tejpar S; Van Cutsem E; Geboes K; Legius E; Matthijs G
Fam Cancer; 2006; 5(2):179-89. PubMed ID: 16736289
[TBL] [Abstract][Full Text] [Related]
38. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
[TBL] [Abstract][Full Text] [Related]
39. Impact of colonoscopic screening in Familial Colorectal Cancer Type X.
Hatfield E; Green JS; Woods MO; Warden G; Parfrey PS
Mol Genet Genomic Med; 2018 Nov; 6(6):1021-1030. PubMed ID: 30300963
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
